These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. The role of cell surface sialic acids for SARS-CoV-2 infection. Sun XL Glycobiology; 2021 Nov; 31(10):1245-1253. PubMed ID: 33909065 [TBL] [Abstract][Full Text] [Related]
3. Biomechanical characterization of SARS-CoV-2 spike RBD and human ACE2 protein-protein interaction. Cao W; Dong C; Kim S; Hou D; Tai W; Du L; Im W; Zhang XF Biophys J; 2021 Mar; 120(6):1011-1019. PubMed ID: 33607086 [TBL] [Abstract][Full Text] [Related]
4. Identification of a Pentasaccharide Lead Compound with High Affinity to the SARS-CoV-2 Spike Protein via In Silico Screening. Li B; Zhang T; Cao H; Ferro V; Li J; Yu M Int J Mol Sci; 2023 Nov; 24(22):. PubMed ID: 38003304 [TBL] [Abstract][Full Text] [Related]
5. SARS-CoV-2 spike protein receptor-binding domain N-glycans facilitate viral internalization in respiratory epithelial cells. Zheng L; Ma Y; Chen M; Wu G; Yan C; Zhang XE Biochem Biophys Res Commun; 2021 Nov; 579():69-75. PubMed ID: 34592572 [TBL] [Abstract][Full Text] [Related]
7. Withanone from Balkrishna A; Pokhrel S; Singh H; Joshi M; Mulay VP; Haldar S; Varshney A Drug Des Devel Ther; 2021; 15():1111-1133. PubMed ID: 33737804 [TBL] [Abstract][Full Text] [Related]
8. Tinocordiside from Balkrishna A; Pokhrel S; Varshney A Comb Chem High Throughput Screen; 2021; 24(10):1795-1802. PubMed ID: 33172372 [TBL] [Abstract][Full Text] [Related]
9. Molecular interactions between perlecan LG3 and the SARS-CoV-2 spike protein receptor binding domain. Gressett TE; Hossen ML; Talkington G; Volic M; Perez H; Tiwari PB; Chapagain P; Bix G Protein Sci; 2024 Jan; 33(1):e4843. PubMed ID: 37996967 [TBL] [Abstract][Full Text] [Related]
10. Structural basis of severe acute respiratory syndrome coronavirus 2 infection. Ge J; Zhang S; Zhang L; Wang X Curr Opin HIV AIDS; 2021 Jan; 16(1):74-81. PubMed ID: 33186231 [TBL] [Abstract][Full Text] [Related]
11. Characterization of the receptor-binding domain (RBD) of 2019 novel coronavirus: implication for development of RBD protein as a viral attachment inhibitor and vaccine. Tai W; He L; Zhang X; Pu J; Voronin D; Jiang S; Zhou Y; Du L Cell Mol Immunol; 2020 Jun; 17(6):613-620. PubMed ID: 32203189 [TBL] [Abstract][Full Text] [Related]
12. Molecular basis for higher affinity of SARS-CoV-2 spike RBD for human ACE2 receptor. Delgado JM; Duro N; Rogers DM; Tkatchenko A; Pandit SA; Varma S Proteins; 2021 Sep; 89(9):1134-1144. PubMed ID: 33864655 [TBL] [Abstract][Full Text] [Related]
13. The molecular basis for SARS-CoV-2 binding to dog ACE2. Zhang Z; Zhang Y; Liu K; Li Y; Lu Q; Wang Q; Zhang Y; Wang L; Liao H; Zheng A; Ma S; Fan Z; Li H; Huang W; Bi Y; Zhao X; Wang Q; Gao GF; Xiao H; Tong Z; Qi J; Sun Y Nat Commun; 2021 Jul; 12(1):4195. PubMed ID: 34234119 [TBL] [Abstract][Full Text] [Related]
14. Dual nature of human ACE2 glycosylation in binding to SARS-CoV-2 spike. Mehdipour AR; Hummer G Proc Natl Acad Sci U S A; 2021 May; 118(19):. PubMed ID: 33903171 [TBL] [Abstract][Full Text] [Related]
15. Characterization of Critical Determinants of ACE2-SARS CoV-2 RBD Interaction. Brown EEF; Rezaei R; Jamieson TR; Dave J; Martin NT; Singaravelu R; Crupi MJF; Boulton S; Tucker S; Duong J; Poutou J; Pelin A; Yasavoli-Sharahi H; Taha Z; Arulanandam R; Surendran A; Ghahremani M; Austin B; Matar C; Diallo JS; Bell JC; Ilkow CS; Azad T Int J Mol Sci; 2021 Feb; 22(5):. PubMed ID: 33668756 [TBL] [Abstract][Full Text] [Related]
16. Identification of SARS-CoV-2 Receptor Binding Inhibitors by In Vitro Screening of Drug Libraries. David AB; Diamant E; Dor E; Barnea A; Natan N; Levin L; Chapman S; Mimran LC; Epstein E; Zichel R; Torgeman A Molecules; 2021 May; 26(11):. PubMed ID: 34072087 [TBL] [Abstract][Full Text] [Related]
17. Molecular Basis of Mink ACE2 Binding to SARS-CoV-2 and Its Mink-Derived Variants. Su C; He J; Han P; Bai B; Li D; Cao J; Tian M; Hu Y; Zheng A; Niu S; Chen Q; Rong X; Zhang Y; Li W; Qi J; Zhao X; Yang M; Wang Q; Gao GF J Virol; 2022 Sep; 96(17):e0081422. PubMed ID: 36000849 [TBL] [Abstract][Full Text] [Related]
18. The structural basis of accelerated host cell entry by SARS-CoV-2†. Seyran M; Takayama K; Uversky VN; Lundstrom K; Palù G; Sherchan SP; Attrish D; Rezaei N; Aljabali AAA; Ghosh S; Pizzol D; Chauhan G; Adadi P; Mohamed Abd El-Aziz T; Soares AG; Kandimalla R; Tambuwala M; Hassan SS; Azad GK; Pal Choudhury P; Baetas-da-Cruz W; Serrano-Aroca Á; Brufsky AM; Uhal BD FEBS J; 2021 Sep; 288(17):5010-5020. PubMed ID: 33264497 [TBL] [Abstract][Full Text] [Related]
19. Structure, Dynamics, Receptor Binding, and Antibody Binding of the Fully Glycosylated Full-Length SARS-CoV-2 Spike Protein in a Viral Membrane. Choi YK; Cao Y; Frank M; Woo H; Park SJ; Yeom MS; Croll TI; Seok C; Im W J Chem Theory Comput; 2021 Apr; 17(4):2479-2487. PubMed ID: 33689337 [TBL] [Abstract][Full Text] [Related]
20. The Glycan-Binding Trait of the Sarbecovirus Spike N-Terminal Domain Reveals an Evolutionary Footprint. Guo H; Li A; Lin HF; Liu MQ; Chen J; Jiang TT; Li B; Wang Y; Letko MC; Peng W; Shi ZL J Virol; 2022 Aug; 96(15):e0095822. PubMed ID: 35852351 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]